McSweegan Edward, Weaver Scott C, Lecuit Marc, Frieman Matthew, Morrison Thomas E, Hrynkow Sharon
Global Virus Network, 801 W. Baltimore St., Baltimore, MD 21201, USA.
Institute for Human Infections and Immunity, Galveston National Laboratory Building, 301 University Blvd., Galveston, TX 77555-0610, USA.
Antiviral Res. 2015 Aug;120:147-52. doi: 10.1016/j.antiviral.2015.06.003. Epub 2015 Jun 10.
The recent spread of chikungunya virus to the Western Hemisphere, together with the ongoing Ebola epidemic in West Africa, have highlighted the importance of international collaboration in the detection and management of disease outbreaks. In response to this need, the Global Virus Network (GVN) was formed in 2011. The GVN is a coalition of leading medical virologists in 34 affiliated laboratories in 24 countries, who collaborate to share their resources and expertise. The GVN supports research, promotes training for young scientists, serves as a technical resource for governments, businesses and international organizations, facilitates international scientific cooperation, and advocates for funding and evidence-based public policies. In response to the spread of chikungunya, the GVN formed a task force to identify research gaps and opportunities, including models of infection and disease, candidate vaccines and antivirals, epidemiology and vector control measures. Its members also serve as authoritative sources of information for the public, press, and policy-makers. This article forms part of a symposium in Antiviral Research on "Chikungunya discovers the New World".
基孔肯雅病毒最近在西半球的传播，以及西非持续的埃博拉疫情，凸显了国际合作在疾病暴发检测与管理中的重要性。为满足这一需求，全球病毒网络（GVN）于2011年成立。GVN是由24个国家34个附属实验室的顶尖医学病毒学家组成的联盟，他们合作共享资源与专业知识。GVN支持研究工作，推动对年轻科学家的培训，为政府、企业和国际组织提供技术资源，促进国际科学合作，并倡导资金投入和基于证据的公共政策。针对基孔肯雅病毒的传播，GVN成立了一个特别工作组，以确定研究空白和机会，包括感染与疾病模型、候选疫苗和抗病毒药物、流行病学以及病媒控制措施。其成员还为公众、媒体和政策制定者提供权威信息来源。本文是《抗病毒研究》中关于“基孔肯雅病毒发现新大陆”研讨会的一部分。
